Abstract:Increasing antibiotic resistance in bacteria causing endogenous infections has entailed a need for innovative approaches to therapy and prophylaxis of these infections and raised a new interest in vaccines for prevention of colonization and infection by typically antibiotic resistant pathogens. Nevertheless, there has been a long history of failures in late stage clinical development of this type of vaccines, which remains not fully understood. This article provides an overview on present and past vaccine developments targeting nosocomial bacterial pathogens; it further highlights the specific challenges associated with demonstrating clinical efficacy of these vaccines and the facts to be considered in future study designs. Notably, these vaccines are mainly applied to subjects with preexistent immunity to the target pathogen, transient or chronic immunosuppression and ill-defined microbiome status. Unpredictable attack rates and changing epidemiology as well as highly variable genetic and immunological strain characteristics complicate the development. In views of the clinical need, re-thinking of the study designs and expectations seems warranted: first of all, vaccine development needs to be footed on a clear rationale for choosing the immunological mechanism of action and the optimal time point for vaccination, e.g., (1) prevention (or reduction) of colonization vs. prevention of infection and (2) boosting of a preexistent immune response vs. altering the quality of the immune response. Furthermore, there are different, probably redundant, immunological and microbiological defense mechanisms that provide protection from infection. Their interplay is not well-understood but as a consequence their effect might superimpose vaccine-mediated resolution of infection and lead to failure to demonstrate efficacy. This implies that improved characterization of patient subpopulations within the trial population should be obtained by pro- and retrospective analyses of trial data on subject level. Statistical and systems biology approaches could help to define immune and microbiological biomarkers that discern populations that benefit from vaccination from those where vaccines might not be effective.

The role of vaccines in preventing bacterial antimicrobial resistance

The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline

The Impact of Vaccination as a Strategy to Combat Bacterial Antimicrobial Resistance

Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance

Vaccines designed to reduce antimicrobial resistance

Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections

Vaccine development for bacterial pathogens: advances, challenges and prospects

Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance

Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights

Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies?

Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria

Antibiotic resistance: a global crisis, problems and solutions

Decoding antimicrobial resistance: unraveling molecular mechanisms and targeted strategies

The scope of the antimicrobial resistance challenge

Antimicrobial Resistance: A Growing Serious Threat for Global Public Health

Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches

Novel Antibacterial Strategies for Combating Bacterial Multidrug Resistance.

Promising efficacy of UTI vaccines as an alternative to antibiotics

The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies

Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections

Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy